NSEOutcome of Board Meeting1h ago · 5 Sept 2026, 08:03 pm

Outcome of Board Meeting

Aarey Drugs & Pharmaceuticals Limited · AAREYDRUGS

✦ AI SummaryResults

Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on September 05, 2026, where the Board of Directors considered and approved the Draft of Board Report and its Annexure and Annual Report along with notice for calling the 36th Annual General Meeting of the Company for the Financial Year 31st March 2026.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on September 05, 2026.

Attachments (1)

📄

AAREYDRUGS_05092026200237_Board_Meeting.pdf

pdf

Download →
View document text
MANUFACTURER OF ‘(ey BULK DRUGS & ' IMPORTERS OF DRUGS & PHARMACEUTICALS LTD. SOLVENTS & CHEMICALS H.0: 203/4 SAHAKAR BHAVAN, 340/48 N.N STREET, MUMBAI-400009 ® : (022) 23455543 Email: corporate@aareydrugs.com REGD OFF. & FACTORY: E-34 MIDC, TARAPUR, BOISAR, DIST.-THANE ® (02525) 271049 Email: info@aareydrugs.com CIN:L99999MHI1990PLC056538 Date: 5™ September, 2026 BSE Limited National Stock Exchange of India Limited The Manager, Exchange Plaza Corporate Service Department BandraKurla Complex, P.J. Towers, Dalal Street, Bandra (E), Mumbai40-0 001 Mumbai — 400051 Scrip Code: 524412 NSE Symbol: AAREYDRUGS Sub: Outcome of Board Meeting held on today i.e 5" September, 2026 Dear Sir/Madam, Pursuant to Regulation 30 (read with Part A of Schedule IIl) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), we wish to inform you that a meeting of the Board of Directors of the Company was held today, i.e., Saturday, 5™ September, 2026 at 06:00 P.M. at the registered office of the Company, wherein inter alia, the following matters were considered and approved: 1) The Board of Directors considered and approved the Draft of Board Report and its Annexure and Annual Report along with notice for calling the 36™ Annual General Meeting of the Company for the Financial Year 31st March 2026. 2) The 36" Annual General Meeting of the Members of the Company will be held on Wednesday, 30" day of September, 2026 at 3:00 P.M (IST) through Video Conferencing / Other Audio Visual Means (VC/ OAVM). 3) The Board has approved the Book Closure of Register of Members and Transfer Books and Cut-off date for the purpose of E-voting, for the purpose of 36™ Annual General Meeting. 4) The Board approved the appointment of Scrutinizer Mr. Virendra G. Bhatt as, Practicing Company Secretaries (COP No.124) for scrutinizing the E- voting to be conducted in the 36" Annual General Meeting of the Company. Board meeting commenced at 06:00 P.M and concluded at 7:30 P.M Kindly take the same on record. Thanking you, Yours Faithfully, For Aarey Drugs & Pharmaceuticals Limited Nimit R.Ghatalia Director DIN: 07069841